Please assess the completion status of the following clinical trial:

Trial Title: Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Traumatic pain~* Numeric Pain Rating Scale (NPRS) \>5 /10~* Age between 18 and 75 years old~Exclusion Criteria:~* Medical pain (headache, chest pain,...)~* Respiratory, renal or hepatic insufficiency~* Drug addiction~* Medical or Chirurgical sinus history~* Oxygene saturation \< 90%~* Systolic blood pressure \< 90mmHg~* Head injury with a neurological Glasgow Coma Scale (GCS) \< 14~* Opioid allergy~* Facial traumatism~* Patient unable do understand or assessing NPRS~* Opiates administration within 6 hours before admission

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- IN Sufentanil AND IV Placebo (Type: EXPERIMENTAL): Patient receives silmutaneously intranasal sufentanil spray AND intraveinous placebo administration
- IV Morphine AND IN Placebo (Type: ACTIVE_COMPARATOR): Patient receives silmutaneously intraveinous morphine administration AND intranasal placebo spray

Based on this trial design, predict the completion outcome and termination type (if applicable).